Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5169910 | 0.97 | TSHR (0.39) | TSHRCYP2C19CA1CA2NT5E | |
| SCHEMBL27525935 | 0.88 | — | — | |
| SCHEMBL11288936 | 0.73 | TSHR (0.36) | TSHRCYP2C19CA1CA2NPSR1 | |
| SCHEMBL14734230 | 0.71 | CA1 (0.32) | CA1NPSR1 | |
| SCHEMBL27772667 | 0.71 | TSHR (0.35) | TSHRCYP2C19CA1CA2 | |
| SCHEMBL27229156 | 0.69 | TSHR (0.33) | TSHRCYP2C19CA1 | |
| Sulfuric Acid SCHEMBL5465130 | 0.69 | TSHR (0.39) | TSHRCYP2C19CA1CA2NT5E | |
| SCHEMBL25476022 | 0.67 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL20420692 | 0.67 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL11452245 | 0.67 | GAA (0.36) | TSHRCYP2C19NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167068-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) | 2010-03-31 | — | — | EP | claimed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | claimed |
| EP-2421523-A1 | METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010121969-A1 | METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2010-10-28 | — | — | WO | disclosed |
| EP-2167068-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | disclosed |